GlassScriptPhysician profile
Lisa M Johnson
NPI 1336772771
$849.98
in general payments reported to CMS, 2019-2025
16 companies · $364 in 2025
The $364 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $103 · 2023: $170 · 2024: $212 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $747.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $746.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $216.79 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Astrazeneca Pharmaceuticals LP | $126.75 | 2022-2024 | Airsupra, Andexxa |
| Genentech USA, INC. | $86.67 | 2024 | Xolair |
| Abbvie INC. | $83.27 | 2025 | |
| Phathom Pharmaceuticals, INC. | $44.70 | 2025 | Voquezna |
| Boston Scientific Corporation | $41.99 | 2022-2024 | Vercise |
| Pfizer INC. | $39.07 | 2025 | |
| Qol Medical, LLC | $33.48 | 2025 | Sucraid |
| Ardelyx, INC. | $31.89 | 2025 | Ibsrela |
| Aimmune Therapeutics, INC. | $29.21 | 2025 | Zenpep |
| Regeneron Healthcare Solutions, INC. | $27.78 | 2025 | Dupixent |
| Medtronic, INC. | $21.01 | 2025 | Interstim |
| Janssen Biotech, INC. | $19.41 | 2025 | Tremfya |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.33 | 2025 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $14.95 | 2025 | Eohilia |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.68 | 2024 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.